Neuropsychological and Electrophysiological Effects of Dance Therapy With People With Severe Mental Disorders
NCT ID: NCT06219265
Last Updated: 2024-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
47 participants
INTERVENTIONAL
2023-09-12
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In summary, the groups are:
* Experimental group (n=26): people with SMD receiving dance therapy.
* Control group (n=21): people with SMD who do not receive the dance therapy intervention but do receive their usual pharmacological treatment.
Tests will be administered before the start of the study and at the end of the study, as well as 3 months after the end of the study in order to compare the results between groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
eMove - Dance/Movement Therapy Study
NCT05712928
Dance and Movement Therapy in Patients With Schizophrenia
NCT05500651
The Effects of Three Different Modalities of Exercise in Patients With Schizophrenia
NCT03953664
Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia
NCT06810362
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia
NCT05716802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The 26 people with SMD in the experimental group will participate in a 10-week intervention program with 2 sessions per week in which they will work for 1 hour on memory, attention and executive functions through dance and movement, ending with 10 minutes of Mindfulness.
The 21 people in the control group will not receive any type of dance therapy intervention, but will continue with their usual pharmacological treatment.
The effects will be measured after a treatment of 20 sessions (twice a week). Results will be obtained by analysing EEG parameters (EEG amplitude and frequency) and cognitive functions (BACS and MoCA). On the other hand, at the end of the 20-session programme, tests will also be administered to assess the symptomatology of the severe mental disorder suffered by the person (PANSS) to assess the effects of the program on these variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group 1: people with SMD receiving dance therapy
Intervention group of people with SMD (n=26) who receive a 20-session dance therapy program for 10 weeks with 2 sessions per week in which they work for 1 hour on memory, attention and executive functions through dance and movement, ending with 10 minutes of Mindfulness.
Dance Therapy
A single-centre prospective randomised controlled trial will be conducted with a minimum of 48 patients with severe mental disorder (SMD) who will be randomised into two groups, 1 intervention group receiving dance therapy (n=24) and 1 control group receiving no intervention or treatment (n=24).
In addition, there will be an intervention group of healthy people who will receive dance therapy (n=20).
All the tests, will be carried out with patients with SMD and only the EEG for healthy people, in order to determine their baseline state. The dance therapy program will last for 20 sessions over 10 weeks.
The 44 people in the two experimental groups will participate in a 10-week intervention program with 2 sessions per week in which they will work for 1 hour on memory, attention and executive functions through dance and movement, ending with 10 minutes of Mindfulness.
The 24 people in the control group will not receive any type of intervention.
Control group: people with SMD who do not receive any intervention
This group of 21 persons with SMD will not receive any intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dance Therapy
A single-centre prospective randomised controlled trial will be conducted with a minimum of 48 patients with severe mental disorder (SMD) who will be randomised into two groups, 1 intervention group receiving dance therapy (n=24) and 1 control group receiving no intervention or treatment (n=24).
In addition, there will be an intervention group of healthy people who will receive dance therapy (n=20).
All the tests, will be carried out with patients with SMD and only the EEG for healthy people, in order to determine their baseline state. The dance therapy program will last for 20 sessions over 10 weeks.
The 44 people in the two experimental groups will participate in a 10-week intervention program with 2 sessions per week in which they will work for 1 hour on memory, attention and executive functions through dance and movement, ending with 10 minutes of Mindfulness.
The 24 people in the control group will not receive any type of intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have the capacity to decide and consent.
* Be between 18 and 75 years of age.
* No active consumption of toxic substances (except nicotine).
* Commitment to attend for the entire study period from December 2023 to December 2024.
Exclusion Criteria
* Having a comorbid severe mental disorder, associated intellectual disability, history of severe brain damage or neurological disorder that may function as a confounding factor (Associated organic-type disorder, borderline or lower IQ)
* Active substance abuse (except nicotine)
* Having a cochlear implant, fixed hearing aids or plates in the head.
* Having suffered a concussion to the head with loss of consciousness that subsequently triggered symptoms related to the pathology.
* Having suffered from epileptic seizures.
* Not having the desire to participate in dance therapy sessions for any reason or to undergo electroencephalogram testing.
* Currently involved and participating in another cognitive rehabilitation program.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación Canaria de Terapias Creativas (ASCATEC)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nayra Caballero Estebaranz
Director of ASCATEC and Department of Health Sciences, European University of the Canary Islands
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nayra Caballero Estebaranz
Role: PRINCIPAL_INVESTIGATOR
ASCATEC and European University of the Canary Islands
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASCATEC
Santa Cruz de Tenerife, Canary Islands, Spain
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TFM_01_DANZA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.